Antitumor antibiotic BMY-41219

Details Antitumor antibiotic BMY-41219 Antitumor antibiotic BMY-41219

1992-02-06

1994-09-06

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 42, 536 271, 435 85, A61K 3100

Patent

active

053448235

ABSTRACT:
A new antitumor antibiotic designated BMY-41219 is produced by fermentation of Saccharothrix aerocolonigenes ATCC 39243. The BMY-41219 antibiotic exhibits antitumor activity.

REFERENCES:
patent: 4487925 (1984-12-01), Nettleton, Jr. et al.
patent: 4785085 (1988-11-01), Kaneko et al.
patent: 4808613 (1989-02-01), Kaneko et al.

Affiliated with

Also associated with

Rating

Antitumor antibiotic BMY-41219 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor antibiotic BMY-41219, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor antibiotic BMY-41219 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1329584